Advertisement
Review Article| Volume 32, ISSUE 3, P629-656, September 2005

Download started.

Ok

Treatment of Sexually Transmitted Infections in Pregnancy

  • Lisa M. Hollier
    Correspondence
    Corresponding author
    Affiliations
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Houston Medical School, Lyndon Baines Johnson General Hospital, 5656 Kelly Street, Houston, TX 77026, USA
    Search for articles by this author
  • Kimberly Workowski
    Affiliations
    Division of Infectious Diseases, Emory University, Atlanta, GA 30322, USA

    Guidelines Unit, Epidemiology and Surveillance Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Search for articles by this author
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Perinatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weinstock H.
        • Berman S.
        • Cates W.
        Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.
        Perspect Sex Reprod Health. 2004; 36: 6-10
        • Chesson H.W.
        • Blandford J.M.
        • Gift T.L.
        • et al.
        The estimated direct medical cost of sexually transmitted diseases among American youth, 2000.
        Perspect Sex Reprod Health. 2004; 36: 11-19
        • Gray R.H.
        • Wabwire-Mangen F.
        • Kigozi G.
        • et al.
        Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda.
        Am J Obstet Gynecol. 2001; 185: 1209-1217
        • Goldenberg R.L.
        • Thompson C.
        The infectious origins of stillbirth.
        Am J Obstet Gynecol. 2003; 189: 861-873
        • Goldenberg R.L.
        • Andrews W.W.
        • Yuan A.C.
        • et al.
        Sexually transmitted disease and adverse outcomes of pregnancy.
        Clin Perinatol. 1997; 24: 23-41
        • Centers for Disease Control and Prevention
        Sexually transmitted disease surveillance 2002 supplement, syphilis surveillance report. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta (GA)2004
        • Centers for Disease Control and Prevention
        Sexually transmitted disease surveillance report 2003. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta (GA)2004
        • Genc M.
        • Ledger W.J.
        Syphilis in pregnancy.
        Sex Transm Infect. 2000; 76: 73-79
        • Watson-Jones D.
        • Changalucha J.
        • Gumodoka B.
        • et al.
        Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy.
        J Infect Dis. 2002; 186: 940-947
        • Centers for Disease Control and Prevention
        Sexually transmitted disease treatment guidelines 2002.
        MMWR Recomm Rep. 2002; 51: 1-78
        • Hollier L.M.
        • Hill J.
        • Sheffield J.S.
        • et al.
        State laws regarding prenatal syphilis screening in the United States.
        Am J Obstet Gynecol. 2003; 189: 1178-1183
        • Lumbiganon P.
        • Piaggio G.
        • Villar J.
        • et al.
        The epidemiology of syphilis in pregnancy.
        Int J STD AIDS. 2002; 13: 486-494
        • Wendel G.D.
        Gestational and congenital syphilis.
        Clin Perinatol. 1988; 15: 287-303
        • Augenbraun M.
        • Workowski K.
        Ceftriaxone therapy for syphilis: report from the emerging infections network.
        Clin Infect Dis. 1999; 29: 1337-1338
        • Augenbraun M.H.
        Treatment of syphilis 2001: nonpregnant adults.
        Clin Infect Dis. 2002; 35: S187-S190
        • Wendel Jr, G.D.
        • Sheffield J.S.
        • Hollier L.M.
        • et al.
        Treatment of syphilis in pregnancy and prevention of congenital syphilis.
        Clin Infect Dis. 2002; 35: S200-S209
        • Centers for Disease Control and Prevention
        Azithromycin treatment failures in syphilis infections—San Francisco, California, 2002–2003.
        MMWR Morb Mortal Wkly Rep. 2004; 53: 197-198
        • Wendel Jr, G.D.
        • Stark B.J.
        • Jamison R.B.
        • et al.
        Penicillin allergy and desensitization in serious infections during pregnancy.
        N Engl J Med. 1985; 312: 1229-1232
        • Alexander J.M.
        • Sheffield J.S.
        • Sanchez P.J.
        • et al.
        Efficacy of treatment for syphilis in pregnancy.
        Obstet Gynecol. 1999; 93: 5-8
        • Myles T.D.
        • Elam G.
        • Park-Hwang E.
        • et al.
        The Jarisch-Herxheimer reaction and fetal monitoring changes in pregnant women treated for syphilis.
        Obstet Gynecol. 1998; 92: 859-864
        • Nathan L.
        • Twickler D.M.
        • Peters M.T.
        • et al.
        Fetal syphilis: correlation of sonographic findings and rabbit infectivity testing of amniotic fluid.
        J Ultrasound Med. 1993; 12: 97-101
        • Hollier L.M.
        • Harstad T.W.
        • Sanchez P.J.
        • et al.
        Fetal syphilis: clinical and laboratory characteristics.
        Obstet Gynecol. 2001; 97: 947-953
        • Barton J.R.
        • Thorpe Jr, E.M.
        • Shaver D.C.
        • et al.
        Nonimmune hydrops fetalis associated with maternal infection with syphilis.
        Am J Obstet Gynecol. 1992; 167: 56-58
        • Sheffield J.S.
        • Sanchez P.J.
        • Morris G.
        • et al.
        Congenital syphilis after maternal treatment for syphilis during pregnancy.
        Am J Obstet Gynecol. 2002; 186: 569-573
        • Fleming D.T.
        • McQuillian G.M.
        • Johnson R.E.
        • et al.
        Herpes simplex virus type 2 in the United States, 1976 to 1994.
        N Engl J Med. 1997; 337: 1105-1111
        • Mertz G.J.
        • Rosenthal S.L.
        • Stanberry L.R.
        Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes?.
        Sex Transm Dis. 2003; 30: 801-802
        • Brown Z.A.
        • Selke S.
        • Zeh J.
        • et al.
        The acquisition of herpes simplex virus during pregnancy.
        N Engl J Med. 1997; 337: 509-515
        • Frenkel L.M.
        • Garratty E.M.
        • Shen J.P.
        • et al.
        Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes.
        Ann Intern Med. 1993; 118: 414-418
        • Harger J.H.
        • Amortegui A.J.
        • Meyer M.P.
        • et al.
        Characteristics of recurrent genital herpes simplex infections in pregnant women.
        Obstet Gynecol. 1989; 73: 367-372
        • Hutto C.
        • Arvin A.
        • Jacobs R.
        • et al.
        Intrauterine herpes simplex virus infections.
        J Pediatr. 1987; 110: 97-101
        • Ratanajamit C.
        • Vinther Skriver M.
        • Jepsen P.
        • et al.
        Adverse pregnancy outcomes in women exposed to acyclovir during pregnancy: a population-based observational study.
        Scand J Infect Dis. 2003; 35: 255-259
        • Brown Z.A.
        • Benedetti J.
        • Ashley R.
        • et al.
        Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.
        N Engl J Med. 1991; 324: 1247-1252
        • Koelle D.M.
        • Benedetti J.
        • Langenberg A.
        • et al.
        Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes.
        Ann Intern Med. 1992; 116: 433
        • Wald A.
        • Ericsson M.
        • Krantz E.
        • et al.
        Oral shedding of herpes simplex virus type 2.
        Sex Transm Infect. 2004; 80: 272-276
        • Brown Z.A.
        HSV-2 specific serology should be offered routinely to antenatal patients.
        Rev Med Virol. 2000; 10: 141-144
        • Wald A.
        • Ashley-Morrow R.
        Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
        Clin Infect Dis. 2002; 35: S173-S182
        • Scoular A.
        Using the evidence base on genital herpes: optimizing the use of diagnostic tests and information provision.
        Sex Transm Infect. 2002; 78: 160-165
        • Wilkinson D.
        • Barton S.
        • Cowan F.
        HSV-2 specific serology should not be offered routinely to antenatal patients.
        Rev Med Virol. 2000; 10: 145-153
        • Rouse D.J.
        • Stringer J.S.
        An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes.
        Am J Obstet Gynecol. 2000; 183: 400-406
        • Barnabas R.V.
        • Carabin H.
        • Garnett G.P.
        The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis.
        Sex Transm Infect. 2002; 78: 425-429
        • Corey L.
        • Wald A.
        • Patel R.
        • et al.
        Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
        N Engl J Med. 2004; 350: 11-20
        • Kimberlin D.F.
        • Weller S.
        • Whitley R.J.
        • et al.
        Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
        Am J Obstet Gynecol. 1998; 179: 846-851
        • Stone K.M.
        • Reiff-Eldridge R.
        • White A.D.
        • et al.
        Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984–1999.
        Birth Defects Res A Clin Mol Teratol. 2004; 70: 201-207
        • Kimberlin D.W.
        Neonatal herpes simplex infection.
        Clin Microbiol Rev. 2004; 17: 1-13
        • Spruance S.L.
        • Tyring S.K.
        • DeGregorio B.
        • et al.
        A large-scale placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis.
        Arch Intern Med. 1996; 156: 1729-1735
        • Braig S.
        • Luton D.
        • Sibony O.
        • et al.
        Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding.
        Eur J Obstet Gynecol Reprod Biol. 2001; 96: 55-58
        • Brocklehurst P.
        • Kinghorn G.
        • Carney O.
        • et al.
        A randomized placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection.
        Br J Obstet Gynaecol. 1998; 105: 275-280
        • Scott L.L.
        • Sanchez P.J.
        • Jackson G.L.
        • et al.
        Acyclovir suppression to prevent cesarean section after first episode genital herpes in pregnancy.
        Obstet Gynecol. 1996; 87: 69-73
        • Scott L.L.
        • Hollier L.M.
        • McIntire D.
        • et al.
        Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
        Infect Dis Obstet Gynecol. 2001; 9: 75-80
        • Scott L.L.
        • Hollier L.M.
        • McIntire D.
        • et al.
        Acyclovir suppression to prevent recurrent genital herpes at delivery.
        Infect Dis Obstet Gynecol. 2002; 10: 71-77
        • Stray-Pederson B.
        Acyclovir in late pregnancy to prevent neonatal herpes simples [letter].
        Lancet. 1990; 336: 756
        • Watts D.H.
        • Brown Z.A.
        • Money D.
        • et al.
        A double-blind randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery.
        Am J Obstet Gynecol. 2003; 188: 836-843
        • Sheffield J.S.
        • Hollier L.M.
        • Hill J.B.
        • et al.
        Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review.
        Obstet Gynecol. 2003; 102: 1396-1403
        • Scott L.L.
        • Alexander J.
        Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in term pregnancy.
        Am J Perinatol. 1998; 15: 57-62
        • American College of Obstetricians and Gynecologists
        Management of herpes in pregnancy. Practice Bulletin No. 8. October 1999
        • Brown Z.A.
        • Wald A.
        • Ashley-Morrow R.A.
        • et al.
        Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.
        JAMA. 2003; 289: 203-209
        • Sheffield J.S.
        • Fish D.N.
        • Hollier L.M.
        • et al.
        Acyclovir concentrations in human breast milk after valacyclovir administration.
        Am J Obstet Gynecol. 2002; 186: 100-102
        • Christmas J.T.
        • Wendel G.D.
        • Bawdon R.E.
        • et al.
        Concomitant infection with Neisseria gonorrhoeae and Chlamydia trachomatis in pregnancy.
        Obstet Gynecol. 1989; 74: 295-298
        • Burkman R.T.
        • Tonascia J.A.
        • Atienza M.F.
        • et al.
        Untreated endocervical gonorrhea and endometritis following elective abortion.
        Am J Obstet Gynecol. 1976; 126: 648-651
        • Alger L.S.
        • Lovchik J.C.
        • Hebel J.R.
        • et al.
        The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome.
        Am J Obstet Gynecol. 1988; 159: 397-404
        • Miller Jr, J.M.
        • Maupin R.T.
        • Mestad R.E.
        • et al.
        Initial and repeated screening for gonorrhea during pregnancy.
        Sex Transm Dis. 2003; 30: 728-730
        • Ickovics J.R.
        • Niccolai L.M.
        • Lewis J.B.
        • et al.
        High postpartum rates of sexually transmitted infections among teens: pregnancy as a window of opportunity for prevention.
        Sex Transm Infect. 2003; 79: 469-473
        • Mahon B.E.
        • Rosenman M.B.
        • Graham M.F.
        • et al.
        Postpartum Chlamydia trachomatis and Neisseria gonorrhoeae infections.
        Am J Obstet Gynecol. 2002; 186: 1320-1325
        • Centers for Disease Control and Prevention
        Sexually transmitted diseases treatment guidelines 2002.
        MMWR Recomm Rep. 2002; 51: 1-78
        • Ramus R.
        • Sheffield J.S.
        • Mayfield J.A.
        • et al.
        A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy.
        Am J Obstet Gynecol. 2001; 185: 629-632
        • Brocklehurst P.
        Antibiotics for gonorrhoea in pregnancy.
        Cochrane Database Syst Rev. 2002; 2: CD000098
        • Ross J.D.
        Systemic gonococcal infection.
        Genitourin Med. 1996; 72: 404-407
        • Bataskov K.L.
        • Hariharan S.
        • Horowitz M.D.
        • et al.
        Gonococcal endocarditis complicating pregnancy: a case report and literature review.
        Obstet Gynecol. 1991; 78: 494-496
        • Sozio J.
        • Ness R.B.
        Chlamydial lower genital tract infection and spontaneous abortion.
        Infect Dis Obstet Gynecol. 1998; 6: 8-12
        • Martius J.
        • Krohn M.A.
        • Hillier S.L.
        • et al.
        Relationships of vaginal lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to predict preterm birth.
        Obstet Gynecol. 1988; 71: 89-95
        • Gravett M.G.
        • Nelson H.P.
        • DeRouen T.
        • et al.
        Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome.
        JAMA. 1986; 236: 1899-1903
        • Andrews W.W.
        • Goldenberg R.L.
        • Mercer B.
        • et al.
        The Preterm Prediction Study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth.
        Am J Obstet Gynecol. 2000; 183: 662-668
        • Blanco J.D.
        • Diaz K.C.
        • Lipscomb K.A.
        • et al.
        Chlamydia trachomatis isolation in patients with endometritis after cesarean section.
        Am J Obstet Gynecol. 1985; 152: 278-279
        • Gibbs R.S.
        • Schachter J.
        Chlamydial serology in patients with intra-amniotic infection and controls.
        Sex Transm Dis. 1987; 14: 213-215
        • Isenberg S.J.
        • Apt L.
        • Wood M.
        A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum.
        N Engl J Med. 1995; 332: 562-566
        • Black C.M.
        Current methods of laboratory diagnosis of Chlamydia trachomatis infections.
        Clin Microbiol Rev. 1997; 10: 160-184
        • Kohl K.S.
        • Markowitz L.E.
        • Koumans E.H.
        Developments in the screening for Chlamydia trachomatis: a review.
        Obstet Gynecol Clin North Am. 2003; 30: 637-658
        • Miller Jr, J.M.
        Recurrent chlamydial colonization during pregnancy.
        Am J Perinatol. 1998; 15: 307-309
        • Adair C.D.
        • Gunter M.
        • Stovall T.G.
        • et al.
        Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin.
        Obstet Gynecol. 1998; 91: 165-168
        • Jacobson G.F.
        • Autry A.M.
        • Kirby R.S.
        • et al.
        A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy.
        Am J Obstet Gynecol. 2001; 184: 1352-1354
        • Kacmar J.
        • Cheh E.
        • Montagno A.
        • et al.
        A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy.
        Infect Dis Obstet Gynecol. 2001; 9: 197-202
        • Wehbeh H.A.
        • Ruggeirio R.M.
        • Shahem S.R.
        • et al.
        Single-dose azithromycin for chlamydia in pregnant women.
        J Reprod Med. 1998; 43: 509-514
        • Silverman N.S.
        • Sullivan M.
        • Hochman M.
        • et al.
        A randomized, prospective trial comparing amoxicillin and erythromycin for the treatment of Chlamydia trachomatis in pregnancy.
        Am J Obstet Gynecol. 1994; 170: 829-832
        • Brocklehurst P.
        • Rooney G.
        Interventions for treating genital Chlamydia trachomatis infection in pregnancy.
        Cochrane Database Syst Rev. 2000; : CD000054
        • Cooper W.O.
        • Ray W.A.
        • Griffin M.R.
        Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis.
        Obstet Gynecol. 2002; 100: 101-106
        • Cooper W.O.
        • Griffin M.R.
        • Arbogast P.
        • et al.
        Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis.
        Arch Pediatr Adolesc Med. 2002; 156: 647-650
        • Sorensen H.T.
        • Skriver M.V.
        • Pedersen L.
        • et al.
        Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides.
        Scand J Infect Dis. 2003; 35: 104-106
        • Adimora A.A.
        Treatment of uncomplicated genital Chlamydia trachomatis infections in adults.
        Clin Infect Dis. 2002; 35: S183-S186
        • Hagensee M.E.
        • Slavinsky 3rd, J.
        • Gaffga C.M.
        • et al.
        Seroprevalence of human papillomavirus type 16 in pregnant women.
        Obstet Gynecol. 1999; 94: 653-658
        • Ault K.
        Human papillomavirus infections: diagnosis, treatment and hope for a vaccine.
        Obstet Gynecol Clin North Am. 2003; 30: 809-817
        • Division of STD Prevention
        Prevention of genital HPV infection and sequelae: report of an external consultants' meeting. Department of Health and Human Services: Centers for Disease Control and Prevention, Atlanta (GA)1999
        • Wiley D.J.
        • Douglas J.
        • Beutner K.
        • et al.
        External genital warts: diagnosis, treatment and prevention.
        Clin Infect Dis. 2002; 35: S210-S224
        • Snyder R.R.
        • Hammond T.L.
        • Hankins G.D.V.
        Human papillomavirus associated with poor healing of episiotomy repairs.
        Obstet Gynecol. 1990; 76: 664-667
        • Goldaber K.G.
        • Wendel P.J.
        • McIntire D.D.
        • et al.
        Postpartum perineal morbidity after fourth degree perineal repair.
        Am J Obstet Gynecol. 1993; 168: 489-493
        • Spitzer M.
        • Krumholz B.A.
        • Seltzer V.L.
        The multicentric nature of disease related to human papillomavirus infection of the female lower genital tract.
        Obstet Gynecol. 1989; 73: 303-307
        • Silverberg M.J.
        • Thorsen P.
        • Lindeberg H.
        • et al.
        Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis.
        Obstet Gynecol. 2003; 101: 645-652
        • Smith E.M.
        • Ritchie J.M.
        • Yankowitz J.
        • et al.
        Human papillomavirus prevalence and types in newborns and parents.
        Sex Transm Dis. 2004; 31: 57-62
        • Miller R.A.
        Podophyllin.
        Int J Dermatol. 1985; 24: 491-498
        • Shuey D.L.
        • Buckalew A.R.
        • Wilke T.S.
        • et al.
        Early events following maternal exposure to 5-fluorouracil lead to dysmorphology in cultured embryonic tissues.
        Teratology. 1994; 50: 379-386
        • Arena S.
        • Marconi M.
        • Frega A.
        • et al.
        Pregnancy and condyloma. Evaluation about therapeutic effectiveness of laser CO2 on 115 pregnant women.
        Minerva Ginecol. 2001; 53: 389-396
        • Schwartz D.B.
        • Greenberg M.D.
        • Daoud Y.
        • et al.
        Genital condylomas in pregnancy: use of trichloroacetic acid and laser therapy.
        Am J Obstet Gynecol. 1988; 158: 1407-1416
        • Garozzo G.
        • Nuciforo G.
        • Rocchi C.M.
        • et al.
        Buschke-Lowenstein tumour in pregnancy.
        Eur J Obstet Gynecol Reprod Biol. 2003; 111: 88-90
        • World Health Organization
        Global prevalence and incidence of selected curable sexually transmitted infections. World Health Organization, Geneva (Switzerland)2001: 27
        • Klebanoff M.A.
        • Carey J.C.
        • Hauth J.C.
        • et al.
        Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.
        N Engl J Med. 2001; 345: 487-493
        • Cotch M.F.
        • Pastorek II, J.G.
        • Nugent R.P.
        • et al.
        Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women.
        Obstet Gynecol. 1991; 78: 1087-1092
        • Witkin S.S.
        • Inglis S.R.
        • Polaneczky M.
        Detection of Chlamydia trachomatis and Trichomonas vaginalis by polymerase chain reaction in introital specimens from pregnant women.
        Am J Obstet Gynecol. 1996; 175: 165-167
        • Cotch M.F.
        • Pastorek II, J.G.
        • Nugent R.P.
        • et al.
        Trichomonas vaginalis associated with low birth weight and preterm delivery.
        Sex Transm Dis. 1997; 24: 353-360
        • Krieger J.N.
        • Tam M.R.
        • Stevens C.E.
        • et al.
        Diagnosis of trichomoniasis.
        JAMA. 1988; 259: 1223-1227
        • Draper D.
        • Parker R.
        • Patterson E.
        • et al.
        Detection of Trichomonas vaginalis in pregnant women with the InPouch TV system.
        J Clin Microbiol. 1993; 31: 1016-1018
        • Schwebke J.R.
        • Morgan S.C.
        • Pinson G.B.
        Validity of self obtained vaginal specimens for diagnosis of trichomoniasis.
        J Clin Microbiol. 1997; 35: 1618-1619
        • Kurth A.
        • Whittington W.L.H.
        • Golden M.R.
        • et al.
        Performance of a new, rapid assay for detection of Trichomonas vaginalis.
        J Clin Microbiol. 2004; 42: 2940-2943
        • Pillay A.
        • Lewis J.
        • Ballard R.C.
        Evaluation of Xenostrip-Tv, a rapid diagnostic test for Trichomonas vaginalis infection.
        J Clin Microbiol. 2004; 42: 3853-3856
        • Brown H.L.
        • Fuller D.A.
        • Davis T.E.
        • et al.
        Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens.
        J Clin Microbiol. 2001; 39: 3197-3199
        • Lawing L.
        • Hedges S.
        • Schwebke J.
        Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR.
        J Clin Microbiol. 2000; 38: 3585-3588
        • Madico G.
        • Quinn T.C.
        • Rompalo A.
        • et al.
        Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples.
        J Clin Microbiol. 1998; 36: 3205-3210
        • Gulmezoglu A.M.
        Interventions for trichomoniasis in pregnancy.
        Cochrane Database Syst Rev. 2002; : CD000220
        • Thin R.N.
        • Symonds M.A.E.
        • Booker R.
        • et al.
        Double-blind comparison of a single dose and a five-day course of metronidazole in the treatment of trichomoniasis.
        Br J Vener Dis. 1979; 55: 354-356
        • Hager W.D.
        • Brown S.T.
        • Kraus S.J.
        • et al.
        Metronidazole for vaginal trichomoniasis.
        JAMA. 1980; 244: 1219-1220
        • Forna F.
        • Gulmezoglu A.M.
        Interventions for treating trichomoniasis in women.
        Cochrane Database Syst Rev. 2003; 2: CD000218
        • Roe F.
        Safety of nitroimidazoles.
        Scand J Infect Dis. 1985; 46: 72-78
        • Caro-Paton T.
        • Carvajal A.
        • Martin de Diego I.
        • et al.
        Is metronidazole teratogenic? A meta-analysis.
        Br J Clin Pharmacol. 1997; 44: 179-182
        • Sorensen H.T.
        • Larsen H.
        • Jensen E.S.
        • et al.
        Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women.
        J Antimicrob Chemother. 1999; 44: 854-856
        • Gulmezoglu A.M.
        • Garner P.
        Trichomoniasis treatment in women: a systematic review.
        Trop Med Int Health. 1998; 3: 553-558
        • Karhunan M.
        Placental transfer of metronidazole and tinidazole in early human pregnancy after a single infusion.
        Br J Clin Pharmacol. 1984; 18: 254-257
        • Czeizel A.E.
        • Kazy Z.
        • Vargha P.
        Oral tinidazole treatment during pregnancy and teratogenesis.
        Int J Gynaecol Obstet. 2003; 83: 305-306
        • Klebanoff M.A.
        • Carey J.C.
        • Hauth J.C.
        • et al.
        Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.
        N Engl J Med. 2001; 345: 487-493
        • Kigozi G.G.
        • Brahmbhatt H.
        • Wabwire-Mangen F.
        • et al.
        Treatment of trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a radomized trial in Rakai, Uganda.
        Am J Obstet Gynecol. 2003; 189: 1398-1400
        • Nelson D.B.
        • Macones G.
        Bacterial vaginosis in pregnancy: current findings and future directions.
        Epidemiol Rev. 2002; 24: 102-108
        • Crowley T.
        • Low N.
        • Turner A.
        • et al.
        Antibiotic prophylaxis to prevent post-abortal upper genital tract infection in women bacterial vaginosis: randomised controlled trial.
        BJOG. 2001; 108: 396-402
        • Watts D.H.
        • Krohn M.A.
        • Hillier S.L.
        • et al.
        Bacterial vaginosis as a risk factor for post-cesarean endometritis.
        Obstet Gynecol. 1990; 75: 52-58
        • Koumans E.H.
        • Markowitz L.E.
        • Hogan V.
        • for the CDC BV Working Group
        Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data.
        Clin Infect Dis. 2002; 35: S152
        • Hauth J.C.
        • Goldenberg R.L.
        • Andrews W.W.
        • et al.
        Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.
        N Engl J Med. 1995; 333: 1732-1736
        • Morales W.J.
        • Schorr S.
        • Albritton J.
        Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study.
        Am J Obstet Gynecol. 1994; 171: 345-349
        • McDonald H.M.
        • O'Loughlin J.A.
        • Vigneswaran R.
        • et al.
        Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial.
        Br J Obstet Gynaecol. 1997; 104: 1391-1397
        • Carey J.C.
        • Klebanoff M.A.
        • Hauth J.C.
        • et al.
        Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
        N Engl J Med. 2000; 342: 534-540
        • Ugwumadu A.
        • Manyonda I.
        • Reid F.
        • et al.
        Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial.
        Lancet. 2003; 361: 983-988
        • McGregor J.A.
        • French J.I.
        • Jones W.
        • et al.
        Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream.
        Am J Obstet Gynecol. 1994; 170: 1048-1059
        • Joesoef M.R.
        • Hillier S.L.
        • Wiknjosastro G.
        • et al.
        Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight.
        Am J Obstet Gynecol. 1995; 173: 1527-1531
        • Rosenstein I.J.
        • Morgan D.J.
        • Lamont R.F.
        • et al.
        Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women.
        Infect Dis Obstet Gynecol. 2000; 8: 158-165
        • Vermeulen G.M.
        • Bruinse H.W.
        Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial.
        Br J Obstet Gynaecol. 1999; 106: 652-657
        • Kurkinen-Raty M.
        • Vuopala S.
        • Koskela M.
        • et al.
        A randomized controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis.
        Br J Obstet Gynaecol. 2000; 107: 1427-1432
        • Kekki M.
        • Kurki T.
        • Pelkonen J.
        • et al.
        Vaginal clindamycin in preventing preterm birth and peripartum infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial.
        Obstet Gynecol. 2001; 97: 643-648
        • Kiss H.
        • Petricevic L.
        • Husslein P.
        Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery.
        BMJ. 2004; 329: 371-376
        • Colli E.
        • Landoni M.
        • Parazzini F.
        Treatment of male partners and recurrence of bacterial vaginosis: a randomized trial.
        Genitourin Med. 1997; 73: 267-270
        • Vejtorp M.
        • Bollerup A.C.
        • Vejtorp L.
        • et al.
        Bacterial vaginosis: a double-blind randomized trial of the effect of treatment of the sexual partner.
        Br J Obstet Gynaecol. 1988; 95: 920-926
        • Vazquez J.A.
        • Sobel J.D.
        Mucosal candidiasis.
        Infect Dis Clin North Am. 2002; 16: 793-820
        • Young G.L.
        • Jewell D.
        Topical treatment for vaginal candidiasis (thrush) in pregnancy.
        Cochrane Database Syst Rev. 2001; : CD000225
        • Davis J.E.
        • Frudenfeld J.H.
        • Goddard J.L.
        Comparative evaluation of monistat and mycostatin in the treatment of vulvovaginal candidiasis.
        Obstet Gynecol. 1974; 44: 403-406
        • McNellis D.
        • McLeod M.
        • Lawson J.
        • et al.
        Treatment of vulvovaginal candidiasis in pregnancy. A comparative study.
        Obstet Gynecol. 1977; 50: 674-678
        • Qualey J.R.
        • Cooper C.
        Monistat cream (miconazole nitrate) a new agent for the treatment of vulvovaginal candidiasis.
        J Reprod Med. 1975; 15: 123-125
        • Ruiz-Velasco V.
        • Rosas-Arceo J.
        Prophylactic clotrimazole treatment to prevent mycoses contamination of the newborn.
        Int J Gynaecol Obstet. 1978; 16: 70-71
        • Tan C.G.
        • Good C.S.
        • Milne L.J.
        • et al.
        A comparative trial of six day therapy with clotrimazole and nystatin in pregnant patients with vaginal candidiasis.
        Postgrad Med J. 1974; 50: 102-105
        • Sobel J.
        Management of patients with recurrent vulvovaginal candidiasis.
        Drugs. 2003; 63: 1059-1066
        • Sorensen H.T.
        • Nielsen G.L.
        • Olesen C.
        • et al.
        Risk of malformations and other outcomes in children exposed to fluconazole in utero.
        Br J Clin Pharmacol. 1999; 48: 234-238
        • Felman Y.M.
        • Nikitas J.A.
        Sexually transmitted molluscum contagiosum.
        Dermatologic Clinics. 1983; 1: 103-111
        • Amer M.
        • El-Garib I.
        Permethrin vs. crotamiton and lindane in the treatment of scabies.
        Int J Dermatol. 1992; 31: 357-358